InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（1 笔）
内部人交易记录
董事已披露买入
1
已披露卖出
1
T+90 胜率
0%
T+90 平均收益
-16.8%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Explore the detailed record of transactions filed by Langer Dennis, 董事. Officer active across 3 companies, notably Myriad Genetics INC. In total, 7 reports have been logged. Split: 1 buy · 1 sell. Total volume traded: €111k. Activity tracked since 3 June 2021. The latest transaction was filed on 27 August 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Langer Dennis
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报7 总计
34,534 股@ US$5.15ADSsSEC:0001104659-26-103376:0
15,152 股@ US$8.4999.8% 占其流量ADSsSEC:0001104659-25-099782:0
标准退出：2026年1月12日 (T+90)
297 股@ US$0.732100.0% 占其流量Ordinary SharesSEC:0001104659-24-070017:0
17,275 股0Common StockSEC:0001628280-22-016225:0
30,000 股@ US$25.39100.0% 占其流量Common StockSEC:0001274225-21-000004:0
12,848 股0Common StockSEC:0001274225-21-000002:0
34,722 股Common StockSEC:0000899243-16-012748:0
7 条申报中的 7 条
About Langer Dennis
LANGER DENNIS is Administrateur and is reported for Myriad Genetics INC, Quoin Pharmaceuticals, Ltd. and Dicerna Pharmaceuticals Inc. He has 6 filings in total, and across the sampled recent filings from 2016-02-05 to 2025-10-15, the buy amount is EUR 110875 and the sell amount is EUR 200; the most frequent transaction nature is Attribution.
